Published in Arch Dermatol on May 01, 1975
Absorption of some organic compounds through the skin in man. J Invest Dermatol (1970) 2.70
Percutaneous penetration of some pesticides and herbicides in man. Toxicol Appl Pharmacol (1974) 2.27
A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol (2000) 1.90
How irritant is alcohol? Br J Dermatol (2007) 1.78
Regional variation in percutaneous penetration in man. Pesticides. Arch Environ Health (1971) 1.76
Textile dye dermatitis. J Am Acad Dermatol (1995) 1.76
Regional variation in percutaneous penetration of 14C cortisol in man. J Invest Dermatol (1967) 1.75
Role of teichoic acid in the binding of Staphylococcus aureus to nasal epithelial cells. J Infect Dis (1980) 1.72
Drug-induced psoriasis: an evidence-based overview and the introduction of psoriatic drug eruption probability score. Cutan Ocul Toxicol (2006) 1.67
Time-dependent variations of the skin barrier function in humans: transepidermal water loss, stratum corneum hydration, skin surface pH, and skin temperature. J Invest Dermatol (1998) 1.63
Intrinsic and extrinsic factors in skin ageing: a review. Int J Cosmet Sci (2008) 1.55
Current concepts in parasitology. This scabies pandemic. N Engl J Med (1978) 1.54
Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group. Clin Infect Dis (1993) 1.54
Contact dermatitis in the atopic. Acta Derm Venereol (1970) 1.53
North American Contact Dermatitis Group patch test results for the detection of delayed-type hypersensitivity to topical allergens. J Am Acad Dermatol (1998) 1.51
Treatment of today's scabies and pediculosis. JAMA (1976) 1.51
Microbial flora of atopic dermatitis. Arch Dermatol (1977) 1.51
Influence of area of application of allergen on sensitization in contact dermatitis. Contact Dermatitis (1992) 1.50
Surfactants and experimental irritant contact dermatitis. Contact Dermatitis (1995) 1.49
Competitive adherence as a mechanism of bacterial interference. Can J Microbiol (1983) 1.48
Differential irritant skin responses to tandem application of topical retinoic acid and sodium lauryl sulphate: II. Effect of time between first and second exposure. Br J Dermatol (1997) 1.42
Photocontact dermatitis to halogenated salicylanilides and related compounds. A clinical and histological review of 26 patients. Arch Dermatol (1968) 1.41
Monitoring the European standard series in 10 centres 1996-2000. Contact Dermatitis (2005) 1.41
Topical iontophoretic drug delivery in vivo: historical development, devices and future perspectives. Dermatology (1993) 1.39
Itraconazole oral solution for the treatment of tinea capitis using the pulse regimen. Cutis (1999) 1.37
Patterns of hyaluronan staining are modified by fixation techniques. J Histochem Cytochem (1997) 1.36
Occupational dermatitis in five European dermatological departments. Berufsdermatosen (1971) 1.35
Effects of a systemic antibiotic on nasal bacterial ecology in man. Appl Microbiol (1970) 1.34
Cell renewal in human epidermis. Arch Dermatol (1965) 1.33
The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations--an overview. Skin Pharmacol Appl Skin Physiol (2000) 1.32
Bioequivalence of topical dermatological dosage forms--methods of evaluation of bioequivalence. Pharm Res (1998) 1.31
Bacterial interference among strains of Staphylococcus aureus in man. J Infect Dis (1974) 1.31
Bacterial adherence to nasal mucosal cells. Infect Immun (1977) 1.29
The inhibitory effect of antiallergy drugs on allergen and histamine induced wheal and flare response. J Allergy Clin Immunol (1973) 1.27
Skin reactivity in patients with cancer. Impaired delayed hypersensitivity or faulty inflammatory response? N Engl J Med (1971) 1.24
Antimicrobial activity of sphingosines. J Invest Dermatol (1992) 1.24
Allergic contact dermatitis. Arch Dermatol (1968) 1.23
Comparative study on the antimicrobial effect of 0.5% chlorhexidine gluconate and 70% isopropyl alcohol on the normal flora of hands. Appl Environ Microbiol (1979) 1.23
Percutaneous penetration enhancers: an overview. Skin Pharmacol Physiol (2007) 1.22
Correlation of human in vivo and in vitro cutaneous antimicrobial factors. J Infect Dis (1975) 1.21
In vivo bioavailability and metabolism of topical diclofenac lotion in human volunteers. Pharm Res (1998) 1.20
Elastic properties of human skin: relation to age, sex, and anatomical region. Arch Dermatol Res (1990) 1.20
Degradation of newly synthesized high molecular mass hyaluronan in the epidermal and dermal compartments of human skin in organ culture. J Invest Dermatol (1991) 1.19
Candida and candidiasis. 1. Cultural conditions, epidemiology and pathogenesis. Postgrad Med (1973) 1.19
In vitro and in vivo antistaphylococcal activity of human stratum corneum lipids. Arch Dermatol (1988) 1.18
The use of graded concentrations in studying skin sensitizers: experimental contact sensitization in man. Food Cosmet Toxicol (1974) 1.16
Survival of pathogenic microorganisms on human skin. J Invest Dermatol (1972) 1.15
Effect of prolonged occlusion on the microbial flora, pH, carbon dioxide and transepidermal water loss on human skin. J Invest Dermatol (1978) 1.15
Surface coats containing polysaccharides on human epidermal cells. J Invest Dermatol (1968) 1.14
The contact urticaria syndrome--an updated review. J Am Acad Dermatol (1981) 1.13
Skin permeability in vivo: comparison in rat, rabbit, pig and man. J Invest Dermatol (1972) 1.13
Measurement of the transit time for cells through the epidermis and stratum corneum of the mouse and guinea-pig. Cell Tissue Kinet (1987) 1.13
Topical metronidazole maintains remissions of rosacea. Arch Dermatol (1998) 1.12
Antimicrobial activity of stratum corneum lipids from normal and essential fatty acid-deficient mice. J Invest Dermatol (1989) 1.12
How irritant is water? An overview. Contact Dermatitis (1999) 1.11
The effect of corticosteroids on human epidermal mitotic activity. Arch Dermatol (1971) 1.10
Frequency of application of topical corticosteroids: an overview. Br J Dermatol (1998) 1.09
Reproducibility of allergy epicutaneous test techniques. J Allergy Clin Immunol (1973) 1.09
Candida and candidiasis. 2. Clinical manifestations and therapy of candidal disease. Postgrad Med (1973) 1.08
Methotrexate in psoriasis: revised guidelines. J Am Acad Dermatol (1988) 1.08
A comparison of rabbit and human skin response to certain irritants. Toxicol Appl Pharmacol (1972) 1.08
The role of vehicles in diagnostic patch testing. A reappraisal. Contact Dermatitis (1993) 1.08
A five-year study of cosmetic reactions. J Am Acad Dermatol (1985) 1.08
Importance of the keratinized epithelial cell in bacterial adherence. J Invest Dermatol (1982) 1.08
Aerobic microbial flora of intertrigenous skin. Appl Environ Microbiol (1977) 1.07
Estrogen and skin. An overview. Am J Clin Dermatol (2001) 1.07
An overview of the efficacy of topical corticosteroids in experimental human nickel contact dermatitis. Contact Dermatitis (2000) 1.06
Hyaluronic acid and skin: wound healing and aging. Int J Dermatol (1996) 1.06
Drug release from a suspension with a finite dissolution rate: theory and its application to a betamethasone 17-valerate patch. J Pharm Sci (1994) 1.05
HPLC-accelerator MS measurement of atrazine metabolites in human urine after dermal exposure. Anal Chem (1999) 1.05
Methotrexate for psoriasis. Arch Dermatol (1967) 1.05
Self-consistent simulations of electroporation dynamics in biological cells subjected to ultrashort electrical pulses. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 1.05
Effects of skin occlusion on percutaneous absorption: an overview. Skin Pharmacol Appl Skin Physiol (2001) 1.05
Methotrexate guidelines--revised. J Am Acad Dermatol (1982) 1.04
Percutaneous penetration of steroids in man. J Invest Dermatol (1969) 1.04
Bacterial interference treatment of recurrent furunculosis. 2. Demonstration of the relationship of strain to pathogeneicity. JAMA (1969) 1.04
Use of methotrexate in psoriasis. Arch Dermatol (1972) 1.04
Immediate hypersensitivity to seminal fluid and atopic dermatitis. Arch Dermatol (1980) 1.03
Skin aging. Effect on transepidermal water loss, stratum corneum hydration, skin surface pH, and casual sebum content. Arch Dermatol (1991) 1.03
In vivo percutaneous absorption and decontamination of pesticides in humans. J Toxicol Environ Health (1985) 1.03
Percutaneous penetration and disposition of triclocarban in man: body showering. Arch Environ Health (1975) 1.03
Vitamin B1 is not a systemic mosquito repellent in man. Trans St Johns Hosp Dermatol Soc (1969) 1.03
Minoxidil stimulates cutaneous blood flow in human balding scalps: pharmacodynamics measured by laser Doppler velocimetry and photopulse plethysmography. J Invest Dermatol (1984) 1.02
Expression of heat shock protein 83 in Leishmania is regulated post-transcriptionally. Mol Biochem Parasitol (1994) 1.02
Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany. Cell Mol Life Sci (2011) 1.02
Modern aspects of scabies. Curr Probl Dermatol (1985) 1.01
In vivo biophysical characterization of skin physiological differences in races. Dermatologica (1991) 1.01
Bacterial interference: relating to chronic furunculosis in man. Br J Dermatol (1969) 1.01